Proton Pump Inhibitors Decrease Diversity in Gut Microbiome, Increase Risk for Complications

Before reaching for that daily antacid, you might consider what it’s doing to the trillions of bugs living in your gut. A new Mayo Clinic study in the open access journal Microbiome shows that people who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures. Study coauthor, Dr. Nicholas Chia comments.

Articles You May Like

5 things to know before key FDA panel votes on J&J’s single-shot Covid vaccine today
Slight differences can help distinguish between two similar pediatric brain conditions
A new combination therapy for treating rare, fatal Sanfilippo syndrome in children
SARS-CoV-2 does not infect the entire body in the same way, finds study
Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit

Leave a Reply

Your email address will not be published. Required fields are marked *